Pancreatic Cancer Research

ResearcherUniversity of Yamanashi HospitalActive in the last 2 years

Wataru Izumo

Matched on ORCID iD 0000-0001-7348-1616; OpenAlex author ID A5018445604. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 4 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 10

  1. To Evaluate Whether Pretreatment CA19-9 and DUPAN-2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Ca… First author DOI 10.1002/ags3.70140↗
  2. The post-neoadjuvant absolute lymphocyte count reflects the pathological response and local tumor control in pancreatic cancer. Co-author DOI 10.1007/s00595-026-03412-y↗
  3. Prognostic Significance of Extrapancreatic Invasion in Pancreatic Cancer: Excellent Outcomes in Patients With Disease Confined Within the Pancreas. Co-author DOI 10.21873/anticanres.18011↗
  4. Prognostic Significance of Splenic Vein Invasion for Pancreatic Cancer Patients With Pancreatectomy: A Retrospective Study. Co-author DOI 10.21873/anticanres.17465↗
  5. Re-consideration of Lymph Node Metastasis in Pancreatic Cancer Patients Following Radical Resection: A Retrospective Study. Co-author DOI 10.21873/anticanres.17020↗
  6. Impact of the controlling nutritional status score on severe postoperative complications of pancreaticoduodenectomy for pancreatic cancer. Co-author DOI 10.1007/s00423-021-02151-7↗
  7. Evaluation of the validity of pancreatectomy for very elderly patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00423-021-02170-4↗
  8. Evaluation of the significance of adjuvant chemotherapy in patients with stage ⅠA pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.01.024↗
  9. Evaluation of Early Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine Together With Nab-paclitaxel. Co-author DOI 10.21873/cdp.10053↗
  10. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/00365521.2019.1624816↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daisuke Ichikawa · 5 shared papers, 2024–2026 · strength 1.23
  2. Hiromichi Kawaida · 5 shared papers, 2024–2026 · strength 1.23
  3. Ryo Saito · 3 shared papers, 2026 · strength 0.83
  4. Masakazu Yamamoto · 5 shared papers, 2019–2021 · strength 0.67
  5. Masahiro Shiihara · 5 shared papers, 2019–2021 · strength 0.67
  6. Toru Furukawa · 5 shared papers, 2019–2021 · strength 0.67
  7. Ryo Saito · 2 shared papers, 2024–2025 · strength 0.40

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.